Notice of Clarification to RFA-DA-10-009 (The National Drug Abuse Treatment Clinical Trials Network [U10]): Publication of Frequently Asked Questions (FAQs)

Notice Number: NOT-DA-09-009

Key Dates
Release Date:  July 29, 2009

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

Purpose

The purpose of this notice is to publish the link to a website containing answers to Frequently Asked Questions (FAQs) regarding RFA-DA-10-009 (The National Drug Abuse Treatment Clinical Trials Network [U10]).  These FAQs can be viewed at http://www.nida.nih.gov/CTN/RFAFAQ.html. Additional FAQs will be added to this website as they arise.

Inquiries

Inquiries regarding this Notice should be directed to:

Harold I Perl, PhD
Senior Lead for Behavioral Research, Dissemination and Training
Center for the Clinical Trials Network
National Institute on Drug Abuse
6001 Executive Blvd., MSC 9557
Bethesda, MD 20892-9557
Telephone:  (301) 443-9982
Fax:  (301) 443-2317
E-mail:  hperl@nida.nih.gov

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

Office of Extramural Research (OER) - Home Page Office of Extramural
Research (OER) 		  National Institutes of Health (NIH) - Home Page National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892 		  Department of Health and Human Services (HHS) - Home Page Department of Health
and Human Services (HHS) 		  USA.gov - Government Made Easy

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.